“Stem cells In Veterinary Practice”
Our mission is to educate veterinarians and put cell technology into practice in Russia.
I confirm that I am fully aware of the eligibility criteria and terms of the Purina BetterwithPets Prize and, based on its description, I am eligible to apply:
Yes, I’m eligible
Yes, I’m 18 years old or older
Should you be successful, please confirm your availability to attend:
Additional Skype interview(s) during the week of March 16-20th 2020
The Purina BetterwithPets Forum in Paris, on 3-4th of June 2020
Initiative's representative name
Initiative's representative date of birth
Initiative's representative gender
Headquarters location: country
Headquarters location: city
Where are you making a difference?
Website or social media url(s)
Soon we will have a web-site!
Fostering emotional intelligence and behavioural competences
Revolutionizing veterinary care for pets
What is your current yearly budget for the initiative? If you are an idea stage, what early budget you would need to kick-off and run operations in your first year?
hybrid: a combination of different types of organisations, such as a social enterprise (an organisation that applies commercial strategies to maximize improvements in human and environmental well-being)
1. Founding story: Share a story about the "Aha!" moment that led the founder(s) to get started or the story of how you saw the potential for this project to succeed.
Our company is named CytoGenTest Scientific Center and we specialize in harvesting, accumulating, and storage of stem cells of adult animals in liquid nitrogen for safe transplantation. A director of our company has been trying to advance the idea of incredible stem-cell therapy last 3 years. Our small team had called clinics and offered to give lectures for their veterinarians, but unfortunately, it was not very effective. One day the director came to our office and said he has an idea of what can we do to convince the vets to use cell therapy treatment. He said we need to organize a global event, an International conference and invite the greatest experts in this field. We said it is an amazing idea and we have to do it!
2. The problem: What problem are you helping to solve?
These days some degenerative disorders as osteoarthritis, cardiomyopathy, hip dysplasia, immunological disorders as immune tolerance, diabetes, asthma and inflammatory disorders as spinal cord injury, non-healing wounds, and other long diseases don’t have an effective treatment. In fact, it is the most common disorders of animals. We see the solution to the problem in the changing of main tools of classic veterinary.
3. Your solution: How are you planning to solve this problem? Share your specific approach.
We are planning to organize the International scientific-practical conference “Stem Cells in Veterinary Practice”, where we want to invite Representatives of State and commercial organizations, leading experts in the field of regenerative medicine from countries of North and South America, Europe, and Japan, where this area has been actively developing for more than 15 years. Not only to listen to the speech and presentation of the speakers but also to show a simple process of transplantation of Allogenic Mesenchymal Stem Cells (aMSC) of dogs and horses. The main event of the conference will be an adoption of a resolution on Stem cell therapy for the program of veterinary universities. We want to do it because Russian veterinarians are really mistrustful to innovations, but it is not their fault. Regenerative veterinary medicine in Russia is just beginning to gain ground. Clinical studies are not conducted, but we can change it!
4. Innovation: How are you innovating or using unique approaches to solve the problem?
The stem cell procedure requires the surgical removal of a small (10 ml) sample of adipose tissue using full aseptic technique. The tissue is then transported to our laboratory, where the regenerative cells are isolated and cultured. The method is not new, but we don’t have scientific centers in Russia, which can use the Allogenic Mesenchymal stem cells in pets. We have successful stories of recovery. We want to present our results at the conference!
5. How does your project harness the pet-human bond to help people develop important social competencies (For example: emotional intelligence, collaboration, empathy, resilience, inclusivity) and overcome serious societal issues (for example: violence, abuse, trauma, isolation, abandonment)?
The project directly harnesses the pet-human bond. It is clear why the conference is developing social competence as emotional intelligence, collaboration or empathy. We want to tell you about our overcome serious societal issues. The treatment is publicly available. The use of cell therapy is significantly more beneficial than long-term treatment with pharmacological drugs. Shelters and charitable foundations will be able to raise funds for animal treatment significantly more effectively. As a result, animals will be given to their new families more quickly. The problem of homeless animals (overproduction of animals) was artificially created in Russia in the second half of the 1990s. During this time, millions of Russians picked up homeless animals from the street. Being able to cure and get rid of chronic pain will reduce the number of dogs thrown away. In many diseases, standard therapy leaves animals in a state of chronic pain and has no treatment (For example painkillers are used to treat osteoarthrosis, which not only does not stop degradation, but also have negative side effects).
6. Impact: how has your project made a difference so far in terms of both business outputs and social impact? How do you plan on measuring progress?
Our plan on measuring success and impact on society is really clear. It could be measured by the number of contracts with veterinary clinics and the number of clinical trials. For the 2018 year we had: 2018 - 5 horses, 2019 - 9 horses, 2020 - stem cells are transplanted to 5 dogs. Surveillance is observed.
7. Growth strategies: what are your main strategies for scaling your impact?
As we noticed before, we are planning the adoption of a resolution on the Stem-cell therapy to the program of veterinary universities. In the midterm, we are going to expand the central laboratory by opening new branch offices in Moscow, Belgorod, Kazan, and other Russian cities, tutoring of our experts stem cell scientists. We are going to organize the International conference every year to present our results to the world. In the long term, we are planning to propose a federal law on the use of stem cells in veterinary medicine.
8. Creating shared value: How does your initiative create value for different stakeholders?
Value is created through the experience gained through the public. Extensive clinical researches, which we plan to conduct, will unite veterinarians and scientists of Russia and create a platform for the spread of innovation in society. It will get rid of the misunderstanding of using stem cells in the treatment of animals. The increase in trust, supported by an evidence base, will unite researchers, veterinarians and pet owners to increase the effectiveness of treatment even in hopeless cases.
Our main mission is to create the value of "New Generation Medicine" as a new paradigm along with the value of "Classical Medicine."
9. Financial sustainability plan: can you tell us about your plan to fund your project and how that plan will be sustainable in the short, medium, and long term?
Our goal is to maintain an active interest in the close follow-up of all treated cases and to create the largest Russia-based veterinary stem cell bank.
We present our development in the following stages:
Adoption of the resolution, planning of stages of clinical trials.
Opening of branches, development of an additional education program for veterinarians, a stable
base of regular customers, conducting all stages of clinical trials.
3D designs and cloning are the methods that scientists all over the world are already working on.
10. Team: what is the current composition of your team (types of roles, qualifications, full-time vs. part-time, board members, etc.), and how do you plan to evolve the team’s composition as the project grows?
At this moment there are 21 members in our team: Director- Ph.D, more than 30 articles, full-time;Accountant-full-time;Safety Engineer - full-time;Marketing Consultant-MS degree, more than 5 articles,full-time;Specialist-MS degree, more than 3 articles, full-time; Senior Laboratory Assistant-MS degree in Biology, more than 7 articles, full-time;-Laboratory Assistant- student of Medicine university, coauthor of more than 5 articles, full-time;Head of department -Ph.D., author of 2 patents and oth
11. How do you plan to influence your field of work if you are a winner of this edition of the Purina BetterwithPets Prize?
If we are a winner, we plan to influence our work by
1. Organizing the International scientific and practical conference “Stem Cells in Veterinary Practice” and inviting leading experts in the field of regenerative medicine.
2. Adoption of a resolution on the Stem-cell therapy for the program of Russian veterinary universities.
3. The expansion of the central laboratory.
4. Carrying out marketing and promotion.
12. How did you hear about this challenge?